Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Autologous Adipose Tissue Derived Mesenchymal Progenitor Cells Therapy for Patients With Knee Osteoarthritis by Intra-articular Injection: A Phase I, Prospective, Single-Arm, Dose-escalating Clinical Trial

Next Previous
Trial Profile

Autologous Adipose Tissue Derived Mesenchymal Progenitor Cells Therapy for Patients With Knee Osteoarthritis by Intra-articular Injection: A Phase I, Prospective, Single-Arm, Dose-escalating Clinical Trial

Status: Completed
Phase of Trial: Phase I/II

Latest Information Update: 06 Apr 2016

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 01 Apr 2016 According to ClinicalTrials.gov record number of treatment arms increased from 1 to 3, Secondary endpoint of Adverse Events made Primary and also time frame for this endpoint has been changed from 6 months to 3 months, Time frame for primary endpoint of WOMAC score has been changed from 6 months to 24 months.
  • 05 Dec 2014 Results presented at the 10th Annual World Stem Cell Summit (WSCS) and RegMed Capital Conference (RMCC), according to Cellular Biomedicine Group media release.
  • 05 Dec 2014 Results published in the Media Release.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top